Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Gene Logic Restructures | Contract Pharma

What are you searching for?

Sign in
Breaking News

Gene Logic Restructures

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

A three-month business review by Gene Logic, has confirmed the potential of its drug repositioning and restructured genomics units. According to a company statement, its genomics assets are a key part of the technology platform used in its drug repositioning business. The company is exploring the possibility of using the assets and technologies in areas such as clinical biomarker development and molecular diagnostics.

According to Gene Logic, the review revealed that its prior strategy for turning around the deteriorating genomics business would not reverse declining sales. Also, the restructuring of the unit — including eliminating half of its work force and cutting spending — has left the business focused on core competencies.

The business review has also confirmed the potential of its drug repositioning business, seeking to revive high-quality drug candidates stalled in clinical development for reasons other than toxicity, according to the company.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters